Literature DB >> 7758126

Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues.

M D Witmer-Pack1, W J Swiggard, A Mirza, K Inaba, R M Steinman.   

Abstract

The rat monoclonal antibody NLDC-145, which has been utilized as a marker for mouse dendritic cells in numerous studies, binds an antigen that is more broadly distributed. This antigen is a unique 205-kDa integral membrane glycoprotein called DEC-205, which we have recently purified in quantities sufficient for basic biochemical studies, N-terminal sequencing, and immunization of rabbits. In cytofluorographic experiments, both the new polyclonal antibody and the original monoclonal detected DEC-205 on many classes of nondendritic murine leukocytes, particularly B cells. The quantities of DEC-205 on the surfaces of these cells were 10 to 50 times lower than those on epidermal and bone marrow dendritic cells. Here we utilize these reagents to reassess the tissue distribution of DEC-205 by immunohistochemical staining of frozen sections from a variety of organs, and by multiple-organ immunoblotting. Abundant expression of DEC-205 was confirmed histologically on thymic and intestinal epithelia and on dendritic cells in the T cell areas of peripheral lymphoid organs. In addition, DEC-205 was visualized in several other locations: B lymphocytes within B cell follicles, the stroma of the bone marrow, the epithelia of pulmonary airways, and the capillaries of the brain. Immunoblotting confirmed the presence of substantial levels of DEC-205 protein in lysates prepared from lymphoid tissues and from lung, marrow, and intestine. Thus, while DEC-205 is expressed at high levels by dendritic cells, it is also expressed by a number of other cell types in situ.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758126     DOI: 10.1006/cimm.1995.1110

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  39 in total

Review 1.  The Importance of Dendritic Cells in Maintaining Immune Tolerance.

Authors:  Cindy Audiger; M Jubayer Rahman; Tae Jin Yun; Kristin V Tarbell; Sylvie Lesage
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

2.  A versatile bifunctional dendritic cell targeting vaccine vector.

Authors:  Welson W Wang; Dipankar Das; Mavanur R Suresh
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

3.  A role for the IkappaB family member Bcl-3 in the control of central immunologic tolerance.

Authors:  Xiaoren Zhang; Hongshan Wang; Estefania Claudio; Keith Brown; Ulrich Siebenlist
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

4.  Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells.

Authors:  Scott Barbuto; Juliana Idoyaga; Miquel Vila-Perelló; Maria P Longhi; Gaëlle Breton; Ralph M Steinman; Tom W Muir
Journal:  Nat Chem Biol       Date:  2013-02-17       Impact factor: 15.040

5.  In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge model.

Authors:  Constantine Bitsaktsis; Zulfia Babadjanova; Edmund J Gosselin
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

6.  Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition.

Authors:  Kirsteen M Tullett; Ingrid M Leal Rojas; Yoshihito Minoda; Peck S Tan; Jian-Guo Zhang; Corey Smith; Rajiv Khanna; Ken Shortman; Irina Caminschi; Mireille H Lahoud; Kristen J Radford
Journal:  JCI Insight       Date:  2016-05-19

7.  A GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APC.

Authors:  J Lori Blanchfield; Mark D Mannie
Journal:  J Leukoc Biol       Date:  2010-03       Impact factor: 4.962

8.  Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.

Authors:  Lionel Franz Poulin; Mariolina Salio; Emmanuel Griessinger; Fernando Anjos-Afonso; Ligia Craciun; Ji-Li Chen; Anna M Keller; Olivier Joffre; Santiago Zelenay; Emma Nye; Alain Le Moine; Florence Faure; Vincent Donckier; David Sancho; Vincenzo Cerundolo; Dominique Bonnet; Caetano Reis e Sousa
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

9.  DEC-205 expression on migrating dendritic cells in afferent lymph.

Authors:  Daniel R Gliddon; Jayne C Hope; Gareth P Brooke; Christopher J Howard
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

10.  Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.

Authors:  David Sancho; Diego Mourão-Sá; Olivier P Joffre; Oliver Schulz; Neil C Rogers; Daniel J Pennington; James R Carlyle; Caetano Reis e Sousa
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.